Sarepta Therapeutics


Sarepta Therapeutics Stock Quote
$120.98 $2.73 0.0%
BATS BZX Real Time Price as of May 24, 2019, 3:38 p.m. View Interactive SRPT Charts

A biopharmaceutical company developing therapeutic products principally based on third-generation NEUGENE antisense technology.

News & Analysis: Sarepta Therapeutics

The Fool has written over 300 articles on Sarepta Therapeutics.


Market Moves



3 Stocks Warren Buffett Would Love

Want to invest like the great value investor? These stocks might appeal to you.

3 Top Biotech Stocks to Buy in February

Here's why Viking Therapeutics, Cambrex, and Sarepta Therapeutics are all solid biotech plays this month.

3 Biotech Stocks to Watch in 2019

Clinical-trial and regulatory-review decisions make these three drug developers worth keeping tabs on this year.

Interactive Chart